Patients prefer subcutaneous progesterone over vaginal administration. Unexpected results of a prospective trial

dc.contributor.authorGosalvez Vega, A.
dc.contributor.authorNinchritz, E.
dc.contributor.authorFernández Sánchez, E.
dc.date.accessioned2016-12-16T17:14:50Z
dc.date.available2016-12-16T17:14:50Z
dc.date.issued2016
dc.description.filiationUEMspa
dc.description.impact4.447 JCR (2016) Q1, 8/80 Obstetrics and Ginecology, 3/29 Reproductive Biologyspa
dc.description.sponsorshipSin financiaciónspa
dc.identifier.citationGosalvez Vega, A., Ninchritz, E., Fernandez-Sanchez, E. (2016). Patients prefer subcutaneous progesterone over vaginal administration. Unexpected results of a prospective trial. Fertility and Sterility, 106(3), e323.spa
dc.identifier.doi10.1016/j.fertnstert.2016.07.915
dc.identifier.issn00150282
dc.identifier.urihttp://hdl.handle.net/11268/6105
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsrestricted accessspa
dc.subject.otherProgesteronaspa
dc.subject.uemReproducción humanaspa
dc.subject.unescoFecundidadspa
dc.subject.unescoHormonaspa
dc.titlePatients prefer subcutaneous progesterone over vaginal administration. Unexpected results of a prospective trialspa
dc.typejournal articlespa
dspace.entity.typePublication

Files